Ecuador vs Iceland: New cases tested for RR-/MDR-TB
Ecuador
100.0%
in 2024
Iceland
100.0%
in 2024
Ecuador rank
1st
Iceland rank
1st
New cases tested for RR-/MDR-TB over time
- Ecuador
- Iceland
How they compare
Ecuador currently reports 100.0% against 100.0% in Iceland, a difference of 0.0%.
The two have swapped places 2 times across 13 shared years of data; in 2005 it was Iceland ahead.
Ecuador ranks 1st and Iceland ranks 1st of 192 countries.
Across the 3 decades both report, Ecuador averaged higher in 1 and Iceland in 2.
Head to head by decade
| Decade | Ecuador | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 100.0% | 96.6% | Iceland |
| 2010s | 21.7% | 96.9% | 75.2% | Iceland |
| 2020s | 98.5% | 50.0% | 48.5% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Ecuador or Iceland?
- Ecuador, at 100.0% against 100.0% in Iceland as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Ecuador and Iceland?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Iceland?
- 13 years are reported by both, from 2005 to 2024.
- How do Ecuador and Iceland rank globally for new cases tested for rr-/mdr-tb?
- Ecuador ranks 1st and Iceland ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.